41.87% | % of shares held by all insiders |
30.47% | % of shares held by institutions |
52.41% | % of float held by institutions |
52 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BVF Inc. | 14,571,236 | 30 Dec 2023 | 14.73% | 45,389,400 |
Avidity Partners Management, LP | 4,469,080 | 30 Dec 2023 | 4.52% | 13,921,184 |
Blackrock Inc. | 2,541,952 | 30 Mar 2024 | 2.57% | 7,918,180 |
Redmile Group, LLC | 2,000,000 | 30 Dec 2023 | 2.02% | 6,230,000 |
Morgan Stanley | 1,757,240 | 30 Dec 2023 | 1.78% | 5,473,802 |
Platinum Investment Management Ltd | 1,515,585 | 30 Dec 2023 | 1.53% | 4,721,047 |
Wells Fargo & Company | 1,119,703 | 30 Mar 2024 | 1.13% | 3,487,874 |
Stempoint Capital LP | 434,588 | 30 Dec 2023 | 0.44% | 1,353,741 |
Renaissance Technologies, LLC | 417,579 | 30 Dec 2023 | 0.42% | 1,300,758 |
Deutsche Bank Aktiengesellschaft | 253,375 | 30 Dec 2023 | 0.26% | 789,263 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Blackrock Funds-Health Sciences Opportunity Portfolio | 1,083,340 | 28 Feb 2024 | 1.10% | 3,374,604 |
BlackRock Health Sciences Term Trust | 752,390 | 30 Dec 2023 | 0.76% | 2,343,694 |
iShares Biotechnology ETF | 429,426 | 30 Mar 2024 | 0.43% | 1,337,661 |
Blackrock Health Sciences Trust | 78,180 | 30 Dec 2023 | 0.08% | 243,530 |
Fidelity NASDAQ Composite Index Fund | 54,797 | 30 Mar 2024 | 0.06% | 170,692 |
Pacific Select Fund-Health Sciences Portfolio | 53,150 | 30 Dec 2023 | 0.05% | 165,562 |
Fidelity Select Portfolios - Biotechnology | 27,202 | 30 Mar 2024 | 0.03% | 84,734 |
DFA U.S. Vector Equity Portfolio | 15,821 | 30 Jan 2024 | 0.02% | 49,282 |
DFA U.S. Micro Cap Series | 10,530 | 30 Jan 2024 | 0.01% | 32,800 |
DFA U.S. Core Equity 2 Portfolio | 8,197 | 30 Jan 2024 | 0.01% | 25,533 |